MedTrace Logo

Blue Light Phototherapy

NCT04343586 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-03-17

Study results available
· View outcomes & findings →

Summary

This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.

Conditions

  • Grover's Disease
  • Psoriasis Vulgaris

Interventions

DEVICE

Blue light phototherapy

Phototherapy- Wavelength: 417±15 nm

Sponsors & Collaborators

Principal Investigators

  • Shuai Xu · Northwestern University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2021-12-20
Completion
2022-09-22
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04343586 on ClinicalTrials.gov